Microparticles in angiogenesis: therapeutic potential
- PMID: 21700952
- DOI: 10.1161/CIRCRESAHA.110.233049
Microparticles in angiogenesis: therapeutic potential
Abstract
Considered during the past decades as cell dust, microparticles are now deemed true biomarkers and vectors of biological information between cells. Depending on their origin, the composition of microparticles varies and the subsequent message transported by them, such as proteins, mRNA, or miRNA, can differ. Recent studies have described microparticles as "cargos" of deleterious information in blood vessel wall under pathological situations such as hypertension, myocardial infarction, and metabolic syndrome. In addition, it has been reported that depending on their origin, microparticles also possess a therapeutic potential regarding angiogenesis. Microparticles can act directly through the interaction ligand/receptor or indirectly on angiogenesis by modulating soluble factor production involved in endothelial cell differentiation, proliferation, migration, and adhesion; by reprogramming endothelial mature cells; and by inducing changes in levels, phenotype, and function of endothelial progenitor cells. This results in an increase in formation of in vitro capillary-like tubes and the generation of new vessels in vivo under ischemic conditions, for instance. Taking into consideration these properties of microparticles, recent evidence provides new basis to expand the possibility that microparticles might be used as therapeutic tools in pathologies associated with an alteration of angiogenesis.
Similar articles
-
Circulating microparticles from obstructive sleep apnea syndrome patients induce endothelin-mediated angiogenesis.Biochim Biophys Acta. 2014 Feb;1842(2):202-7. doi: 10.1016/j.bbadis.2013.11.017. Epub 2013 Nov 22. Biochim Biophys Acta. 2014. PMID: 24275556
-
Therapeutic potential of plasma membrane-derived microparticles.Pharmacol Rep. 2009 Jan-Feb;61(1):49-57. doi: 10.1016/s1734-1140(09)70006-4. Pharmacol Rep. 2009. PMID: 19307692 Review.
-
Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury.Circulation. 2010 Aug 3;122(5):495-506. doi: 10.1161/CIRCULATIONAHA.109.909473. Epub 2010 Jul 19. Circulation. 2010. PMID: 20644015
-
Microparticles: biomarkers and beyond.Clin Sci (Lond). 2013 Apr;124(7):423-41. doi: 10.1042/CS20120309. Clin Sci (Lond). 2013. PMID: 23249271 Review.
-
[Endothelial microparticles (EMP) in physiology and pathology].Postepy Hig Med Dosw (Online). 2015 Aug 18;69:925-32. doi: 10.5604/17322693.1165195. Postepy Hig Med Dosw (Online). 2015. PMID: 26400879 Review. Polish.
Cited by
-
Microvesicles: potential markers and mediators of endothelial dysfunction.Curr Opin Endocrinol Diabetes Obes. 2012 Apr;19(2):121-7. doi: 10.1097/MED.0b013e32835057e9. Curr Opin Endocrinol Diabetes Obes. 2012. PMID: 22248645 Free PMC article. Review.
-
Endothelial microparticles: sophisticated vesicles modulating vascular function.Vasc Med. 2013 Aug;18(4):204-14. doi: 10.1177/1358863X13499773. Epub 2013 Jul 26. Vasc Med. 2013. PMID: 23892447 Free PMC article. Review.
-
Exosomes from retinal astrocytes contain antiangiogenic components that inhibit laser-induced choroidal neovascularization.J Biol Chem. 2013 Sep 27;288(39):28058-67. doi: 10.1074/jbc.M113.470765. Epub 2013 Aug 7. J Biol Chem. 2013. PMID: 23926109 Free PMC article.
-
Microvesicles in Atherosclerosis and Angiogenesis: From Bench to Bedside and Reverse.Front Cardiovasc Med. 2017 Dec 18;4:77. doi: 10.3389/fcvm.2017.00077. eCollection 2017. Front Cardiovasc Med. 2017. PMID: 29326946 Free PMC article. Review.
-
The contribution of CXCL12-expressing radial glia cells to neuro-vascular patterning during human cerebral cortex development.Front Neurosci. 2014 Oct 15;8:324. doi: 10.3389/fnins.2014.00324. eCollection 2014. Front Neurosci. 2014. PMID: 25360079 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous